This premier gathering continues to place the pharmaceutical and biotech sectors at the very heart of its foundation - championing the legal strategies, regulatory updates, and innovation shaping the future of IP protection in life sciences.

Across three dynamic days in Amsterdam, attendees will gain front-row access to critical conversations and case law covering:

• Cross-border patent litigation strategy

• The latest UPC developments and landmark rulings

• SPCs, PTEs, Bolar exemptions, and regulatory reform across Europe and the U.S.

• Sector-specific panels on MedTech, small molecule, and large molecule litigation

• Hot-button issues like AI patentability, second medical use claims, skinny labels, and competition law in pharma

View the event here.